Exploratory Study of Breast Cancer With ABY025
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: 111-In-ABY-025
Sponsor: Biomedical Radiation Sciences
Collaborators: Swedish Cancer Society